PAUL SWENSON: Open Payments
NPI 1639434509 · GLENWOOD SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$289 in 14 payments from 10 companies in 2025. Trend: 2023 $221 · 2024 $347 · 2025 $289
Food & beverage: $289
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $52 |
| ABBVIE INC. | 2 | $39 |
| Novo Nordisk Inc | 2 | $34 |
| Amgen Inc. | 2 | $34 |
| Astellas Pharma US Inc | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| PFIZER INC. | 1 | $21 |
| Lilly USA, LLC | 1 | $14 |
Products named: AIRSUPRA, Wegovy, Veozah, REXULTI, Cologuard Collection Kit, M-M-R II, QULIPTA, PREVNAR 20.
Industry payments across CO — which companies pay providers there.
